Drug Pricing Policies in the United States and Globally
From Development to Delivery
Couldn’t join us? Check out the conversation on Twitter: @PetrieFlom #drugpricing and some of our speakers’ slide presentations below!
Description
This one-day conference explored the current pharmaceutical pricing landscape by bringing together leaders from the pharmaceutical industry, policymakers, legal practitioners, and scholars to engage in novel, interdisciplinary discussions to better understand current challenges and articulate best practices to address these issues. Participants assessed the current challenges presented in drug pricing policy, from development to delivery, in both the United States and international context. We also explored and articulated best practices to expand access to medicines and worked toward developing a plan for disseminating these practices more widely.
This event was free and open to the public.
Sponsored by the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School, Global Access in Action at the Berkman Klein Center for Internet and Society at Harvard University, and the Harvard Health Law Society, with support from Gilead Sciences, Inc.
Agenda
8:00 – 8:30am, Registration
8:30 – 8:45am, Welcome Remarks
8:45 – 9:30am, Keynote Address
9:30 – 10:45am, Panel I: From Development to Delivery in the United States
10:45 – 11:00am, Break
11:00am – 12:15pm, Panel II: From Development to Delivery Globally
12:15 – 12:45pm, Keynote Address
12:45 – 1:45pm, Networking Lunch
1:45 – 3:00pm, Panel III: Best Practices in Pricing Policy for Essential Drugs
3:00 – 3:15pm, Break
3:15 – 4:30pm, Panel IV: Innovations in Drug Discovery and Policy
Sponsored by the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School, Global Access in Action at the Berkman Klein Center for Internet and Society at Harvard University, and the Harvard Health Law Society, with support from Gilead Sciences, Inc. and the Center for Bioethics at Harvard Medical School and the Oswald DeN. Cammann Fund at Harvard University.